Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SOD1 | P00441 | 1/20 | 0.77 |
| ▸ | KARS1 | Q15046 | 2/20 | 0.73 |
| ▸ | RXRA | P19793 | 1/20 | 0.73 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.73 |
| ▸ | CDK2 | P24941 | 1/20 | 0.73 |
| ▸ | RXRB | P28702 | 1/20 | 0.73 |
| ▸ | RXRG | P48443 | 1/20 | 0.73 |
| ▸ | POLB | P06746 | 1/20 | 0.71 |
| ▸ | APEX1 | P27695 | 1/20 | 0.71 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.71 |
| ▸ | NR1H2 | P55055 | 8/20 | 0.68 |
| ▸ | NR1H3 | Q13133 | 8/20 | 0.68 |
| ▸ | POLA1 | P09884 | 4/20 | 0.65 |
| ▸ | LMNA | P02545 | 1/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.58 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.57 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15588775 | 1.00 | SOD1 (0.77) | SOD1KARS1RXRACCNE1CDK2 | |
| SCHEMBL7024094 | 1.00 | SOD1 (0.77) | SOD1KARS1RXRACCNE1CDK2 | |
| Paraben SCHEMBL7028893 | 0.93 | PDE4D (0.70) | SOD1KARS1RXRACCNE1CDK2 | |
| Podocaric Acid SCHEMBL32474685 | 0.91 | NR1H2 (0.80) | SOD1KARS1RXRACCNE1CDK2 | |
| Podocaric Acid SCHEMBL6311820 | 0.91 | NR1H2 (0.80) | SOD1KARS1RXRACCNE1CDK2 | |
| Podocaric Acid SCHEMBL14389445 | 0.91 | NR1H2 (0.80) | SOD1KARS1RXRACCNE1CDK2 | |
| Podocaric Acid SCHEMBL31181390 | 0.91 | NR1H2 (0.80) | SOD1KARS1RXRACCNE1CDK2 | |
| Podocaric Acid SCHEMBL160062 | 0.91 | NR1H2 (0.80) | SOD1KARS1RXRACCNE1CDK2 | |
| Podocaric Acid SCHEMBL6312979 | 0.90 | NR1H2 (0.78) | SOD1KARS1RXRACCNE1CDK2 | |
| SCHEMBL17927225 | 0.89 | KARS1 (0.71) | SOD1KARS1RXRACCNE1CDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140363530-A1 | COMPOSITION COMPRISING THE EXTRACT OF PINE TREE LEAF OR THE COMPOUNDS ISOLATED THEREFROM FOR THE PREVENTION AND TREATMENT OF CANCER DISEASE BY INHIBITING HPV VIRUS AND THE USES THEREBY | GUEULRI (KR) | 2014-12-11 | — | — | US | claimed |
| EP-2788311-A1 | A COMPOSITION COMPRISING THE EXTRACT OF PINE TREE LEAF OR THE COMPOUNDS ISOLATED THEREFROM FOR THE PREVENTION AND TREATMENT OF CANCER DISEASE BY INHIBITING HPV VIRUS AND THE USES THEREBY | Gueulri (KR) | 2014-10-15 | — | — | EP | claimed |
| WO-2013180462-A1 | A COMPOSITION COMPRISING THE EXTRACT OF PINE TREE LEAF OR THE COMPOUNDS ISOLATED THEREFROM FOR THE PREVENTION AND TREATMENT OF CANCER DISEASE BY INHIBITING HPV VIRUS AND THE USES THEREBY | GUEULRI (KR) | 2013-12-05 | — | — | WO | claimed |
| US-20130045954-A1 | ANTIMICROBIAL COMPOSITION | UNIVERSITY OF SURREY (GB) | 2013-02-21 | — | — | US | claimed |
| US-9743675-B2 | Antimicrobial composition | UNIVERSITY OF SURREY (GB) | 2017-08-29 | — | — | US | disclosed |
| CN-102630141-B | Antimicrobial compositions | UNIVERSITY OF SURREY (GB) | 2015-09-23 | — | — | CN | disclosed |
| US-20150246087-A1 | EXTRACTS AND THERAPEUTIC USES THEREOF | REGENERA PHARMA LTD. (IL) | 2015-09-03 | — | — | US | disclosed |
| US-20140363530-A1 | COMPOSITION COMPRISING THE EXTRACT OF PINE TREE LEAF OR THE COMPOUNDS ISOLATED THEREFROM FOR THE PREVENTION AND TREATMENT OF CANCER DISEASE BY INHIBITING HPV VIRUS AND THE USES THEREBY | GUEULRI (KR) | 2014-12-11 | — | — | US | disclosed |
| EP-2788311-A1 | A COMPOSITION COMPRISING THE EXTRACT OF PINE TREE LEAF OR THE COMPOUNDS ISOLATED THEREFROM FOR THE PREVENTION AND TREATMENT OF CANCER DISEASE BY INHIBITING HPV VIRUS AND THE USES THEREBY | Gueulri (KR) | 2014-10-15 | — | — | EP | disclosed |
| WO-2013180462-A1 | A COMPOSITION COMPRISING THE EXTRACT OF PINE TREE LEAF OR THE COMPOUNDS ISOLATED THEREFROM FOR THE PREVENTION AND TREATMENT OF CANCER DISEASE BY INHIBITING HPV VIRUS AND THE USES THEREBY | GUEULRI (KR) | 2013-12-05 | — | — | WO | disclosed |
| US-20130045954-A1 | ANTIMICROBIAL COMPOSITION | UNIVERSITY OF SURREY (GB) | 2013-02-21 | — | — | US | disclosed |
| CN-102630141-A | Antimicrobial composition | UNIV SURREY | 2012-08-08 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130045954-A1 | ANTIMICROBIAL COMPOSITION | EBP, CLPP, ELANE | SOD1 253/4885KARS1 3490/4885RXRA 1972/4885 |
| US-20140363530-A1 | COMPOSITION COMPRISING THE EXTRACT OF PINE TREE LEAF OR THE COMPOUNDS ISOLATED THEREFROM FOR THE PREVENTION AND TREATMENT OF CANCER DISEASE BY INHIBITING HPV VIRUS AND THE USES THEREBY | VHL, TP53, PNN | SOD1 1053/4885KARS1 1937/4885RXRA 3013/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.